I don't know that it could be done using lenti, as frameshift is unlikely to be sufficient. However, there have been publications with increasingly large sections of DNA removed from chromosomes and so creating a clonal cell line lacking the sequence would be quite feasible
We used classical CRISPr to successfully deplete one lncRNA (double nicking system with a recombination donor vector harboring 2 flanking arms and a puromycin resistance gene in between). It works wonderful !. In fact I was thinking in using iCRISPR, but because of the low levels of expression of lncRNAs, I preferred to completely knock-down the gene.
If I were you I would try to deplete lncRNA at RNA level because mostly they are in non-coding regions and it'll take a long time to have a comprehensive knowledge about this part of genome. For manipulating RNAs by CRISPR/CAS9 you should see Dr. Doudna's report " Programmable RNA recognition and cleavage by CRISPR/Cas9" where they introduce PAMmers to RCas9.
recent report from J. Weissman lab ( Cell 2013,) nicely reported depletion of several lcnRNAs by CRISPri. One could compare this method with introduction of 3xpoly A site and ask is it the RNA or active transcription that is important for lncRNA functions.
This is different, since is a transcriptional inhibition by steric interference of an inactive Cas9 protein with the polymerase. However, a beautiful paper by Jeniffer Doudna in Nature showed how to use CRISPr to degrade directly RNAs, instead of DNAs. Take a look
I have managed to delete 4 kb of lncRNA gene using Nickase version of Cas9 (with 2 pairs of guides on either side of a gene). I also use CRISPRi or CRISPR ON effectively on various lncRNAs in mouse ESC and MEFs.
Madapura Marulasiddappa Pradeepa : Hi, I am trying a similar strategy for deleting LincRNA in mESC's. Can you share the protocol that worked for you?. It will be very helpful for me.
I have been talking to a representative from Sigma that suggested me to use two vectors expressing gRNAs designed at the beginning of the first exon and at the end of the last exon. After co-transfection of the two vectors (expressing also Cas9 of course) one can select for repair events that remove the entire lncRNA gene..... I'm consifering to give it a try. But maybe not with the vectors but with gRNAs and Cas9 transfection...
If you are interested, please drop me a line at the email address in the paper. We found CRISPR KO by paired guides to be pretty effective at knocking down lncRNA expression.
Thanks Rory for sharing your paper, it is indeed a useful method for probing the function of regulatory elements. I will go through the paper soon. Are these plasmids deposited to Addgene?
Dear Lovorka, thanks for such question. I wonder if i could get the general protocol that worked for CRISPi in lncRNA and regards the method of transfection was lipofectamine or something else?
Yes, CRISPR interference (CRISPRi) has indeed been applied to the study of long noncoding RNAs (lncRNAs). CRISPRi, which typically uses a deactivated Cas9 (dCas9) fused to a transcriptional repressor, allows for targeted silencing of gene expression, and it has been effectively utilized to investigate the functions of lncRNAs in various biological contexts. Here’s a detailed explanation of how CRISPRi is applied to lncRNAs:
Target Selection:The first step involves selecting specific target sites within the lncRNA sequence. Unlike protein-coding genes, lncRNAs do not have clear exons and introns structure, which can complicate target site selection. Typically, regions near the transcription start site (TSS) of the lncRNA are targeted to effectively repress transcription.
Guide RNA Design:Design guide RNAs (gRNAs) that are specific to the chosen target sites. The specificity is crucial to avoid off-target effects, which are a common concern in RNA-targeting applications due to the potential for partial complementarity.
Vector Construction:Construct expression vectors encoding the dCas9-repressor fusion protein and the designed gRNAs. Common repressors used in CRISPRi include the Krüppel-associated box (KRAB) domain.
Cell Transfection:Transfect the vectors into the cell line or organism where the lncRNA function is to be studied. Effective delivery and expression of the dCas9-repressor and gRNA are critical for successful transcriptional repression.
Functional Assays:After CRISPRi-mediated repression of the lncRNA, perform functional assays to determine the impact on the cell. These can include assays for cell proliferation, apoptosis, migration, and other relevant biological processes. Additionally, RNA sequencing and other transcriptomic approaches can be employed to examine changes in global gene expression patterns caused by the knockdown of the lncRNA.
Validation:Validate the specific repression of the lncRNA using quantitative PCR (qPCR) or RNA sequencing to confirm that the decrease in RNA levels is due to the CRISPRi system. This also involves checking for potential off-target effects by examining the expression of other lncRNAs or similar sequences.
Experimental Replication:It's important to replicate experiments in different cell lines or biological replicates to ensure that the observed effects are consistent and not due to experimental artifacts or cell line-specific responses.
CRISPRi has provided researchers with a powerful tool for studying the often elusive functions of lncRNAs, which are increasingly recognized for their roles in regulating gene expression, cellular differentiation, and disease pathology. By selectively repressing lncRNAs in a controlled manner, scientists can dissect their functional roles and potentially uncover new therapeutic targets.
With this protocol list, we might find more ways to solve this problem.